Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NXTC Nextcure Inc.

盘前交易 04-23 05:19:21 EDT

0.4005

+0.0315

+8.54%

最高0.4124	最低0.3751	成交量37.61万
今开0.4000	昨收0.3690	日振幅10.11%
总市值1,122万	流通市值843.76万	总股本2,801万
成交额14.82万	换手率1.79%	流通股本2,107万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":0.4005,"timestamp":1745352000000,"preClose":0.369,"halted":0,"volume":376075,"delay":0,"floatShares":21067775,"shares":28006684,"eps":-2.094523,"marketStatus":"盘前交易","change":0.0315,"latestTime":"04-23 05:19:21 EDT","open":0.4,"high":0.4124,"low":0.3751,"amount":148153.08023775002,"amplitude":0.101084,"askPrice":0.4765,"askSize":100,"bidPrice":0.3119,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.094523,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745415000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":0.4006,"postHourTrading":{"tag":"盘后","latestPrice":0.4005,"preClose":0.4005,"latestTime":"19:49 EDT","volume":3,"amount":1.1451,"timestamp":1745365797118},"volumeRatio":1.311617144869417,"impliedVol":1.7548,"impliedVolPercentile":0.9197},"requestUrl":"/m/hq/s/NXTC","defaultTab":"news","newsList":[{"id":"2529864595","title":"Nextcure, Inc.盘中异动 股价大涨8.40%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529864595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529864595?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:45","pubTimestamp":1745329540,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时45分，Nextcure, Inc.股票出现波动，股价大幅拉升8.40%。截至发稿，该股报0.400美元/股，成交量7938股，换手率0.03%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214541a6c3ddf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214541a6c3ddf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","LU0266512127.USD","BK4139","BK4213","NXTC","CRC"],"gpt_icon":0},{"id":"2529980297","title":"Nextcure, Inc.盘中异动 急速拉升7.67%报0.389美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529980297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529980297?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:48","pubTimestamp":1745243295,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时48分，Nextcure, Inc.股票出现波动，股价急速拉升7.67%。截至发稿，该股报0.389美元/股，成交量6.6601万股，换手率0.24%，振幅4.18%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214815973f7620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214815973f7620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","CRC","BK4213","BK4139","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":0},{"id":"2528274504","title":"Nextcure, Inc.盘中异动 早盘股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528274504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528274504?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:45","pubTimestamp":1744897525,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时45分，Nextcure, Inc.股票出现异动，股价快速拉升5.70%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417214525aa2c72fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417214525aa2c72fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","NXTC","BK4139","LU0266512127.USD","LU0456854461.SGD","BK4213"],"gpt_icon":0},{"id":"2527244957","title":"Nextcure, Inc.盘中异动 急速下跌6.22%报0.312美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527244957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527244957?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:35","pubTimestamp":1744810521,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时35分，Nextcure, Inc.股票出现波动，股价快速下跌6.22%。截至发稿，该股报0.312美元/股，成交量4669股，换手率0.02%，振幅2.55%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213521a45b2e62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213521a45b2e62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","NXTC","LU0266512127.USD","LU0456854461.SGD","BK4213","BK4139"],"gpt_icon":0},{"id":"2527741729","title":"Nextcure, Inc.股价飙升25.99% 市值涨286.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527741729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527741729?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:32","pubTimestamp":1744723922,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时32分，Nextcure, Inc.股票出现异动，股价急速拉升25.99%。截至发稿，该股报0.393美元/股，成交量2695股，换手率0.01%，振幅23.75%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213202a459c527&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213202a459c527&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","NXTC","LU0266512127.USD","LU0456854461.SGD","CRC","BK4139"],"gpt_icon":0},{"id":"2518284977","title":"Nextcure, Inc.2024财年实现净利润-55.65百万美元，同比增加11.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518284977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518284977?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536082,"startTime":"0","endTime":"0","summary":"3月10日，Nextcure, Inc.公布财报，公告显示公司2024财年净利润为-55.65百万美元，同比增加11.27%；其中营业收入为0.00美元，每股基本收益为-1.99美元。从资产负债表来看，Nextcure, Inc.总负债16.45百万美元，其中短期债务796000.00美元，资产负债比为4.98，流动比率为7.51。机构评级：截至2025年3月10日，当前有2家机构对Nextcure, Inc.目标价做出预测，其中目标均价为3.00美元，其中最低目标价为3.00美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000304a2689894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000304a2689894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC"],"gpt_icon":0},{"id":"2517145291","title":"NextCure(NXTC.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.41美元，前值为-0.52美元，预期值为-0.36美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517145291","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517145291?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:57","pubTimestamp":1741301839,"startTime":"0","endTime":"0","summary":"NextCure(NXTC.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.41美元，前值为-0.52美元，预期值为-0.36美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07065748578832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NXTC"],"gpt_icon":0},{"id":"1113678994","title":"NextCure 2024财年GAAP每股收益$(1.99)不及预期$(1.92)","url":"https://stock-news.laohu8.com/highlight/detail?id=1113678994","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113678994?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:19","pubTimestamp":1741295952,"startTime":"0","endTime":"0","summary":"NextCure（NASDAQ:NXTC）报告季度每股亏损$(1.99)，低于分析师一致预期$(1.92)，差幅为3.65%。以上内容来自Benzinga Earnings专栏，原文如下：NextCure (NASDAQ:NXTC) reported quarterly losses of $(1.99) per share which missed the analyst consensus estimate of $(1.92) by 3.65 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NextCure 2024财年GAAP每股收益$(1.99)不及预期$(1.92)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC"],"gpt_icon":0},{"id":"2517167564","title":"Nextcure, Inc.盘中异动 早盘大幅上涨5.41%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517167564?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:04","pubTimestamp":1741277091,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时04分，Nextcure, Inc.股票出现异动，股价快速上涨5.41%。截至发稿，该股报0.780美元/股，成交量2.2204万股，换手率0.08%，振幅4.36%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000451abeb8e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000451abeb8e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","CRC","LU0456854461.SGD","BK4139","LU0266512127.USD","NXTC"],"gpt_icon":0},{"id":"2517943623","title":"Nextcure, Inc.盘中异动 大幅拉升5.53%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943623?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186149,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分，Nextcure, Inc.股票出现波动，股价急速上涨5.53%。截至发稿，该股报0.780美元/股，成交量770股，换手率0.00%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224909963ae0f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224909963ae0f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","NXTC","BK4139","LU0456854461.SGD","BK4213","LU0266512127.USD"],"gpt_icon":0},{"id":"2517067216","title":"Nextcure, Inc.盘中异动 快速下跌7.98%报0.671美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517067216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517067216?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:09","pubTimestamp":1741104554,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时09分，Nextcure, Inc.股票出现波动，股价大幅下跌7.98%。截至发稿，该股报0.671美元/股，成交量1.0797万股，换手率0.04%，振幅5.49%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030500091496395e97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030500091496395e97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","BK4213","BK4139","LU0456854461.SGD","NXTC","LU0266512127.USD"],"gpt_icon":0},{"id":"2516668245","title":"Nextcure, Inc.盘中异动 下午盘股价大跌6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668245?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:31","pubTimestamp":1741030270,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时31分，Nextcure, Inc.股票出现异动，股价大幅下跌6.41%。截至发稿，该股报0.729美元/股，成交量6210股，换手率0.02%，振幅4.49%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033111989a519e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033111989a519e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","BK4213","NXTC","CRC","BK4139","LU0266512127.USD"],"gpt_icon":0},{"id":"2514200733","title":"Nextcure, Inc.盘中异动 股价大跌8.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514200733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514200733?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:33","pubTimestamp":1740753228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分，Nextcure, Inc.股票出现异动，股价大幅下挫8.74%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223349963419e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223349963419e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0266512127.USD","NXTC","BK4213","CRC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2513472061","title":"Nextcure, Inc.盘中异动 早盘大幅拉升6.38%报0.769美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513472061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513472061?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:00","pubTimestamp":1740409211,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时00分，Nextcure, Inc.股票出现波动，股价快速拉升6.38%。截至发稿，该股报0.769美元/股，成交量3473股，换手率0.01%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242300129890fcec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242300129890fcec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","BK4213","LU0456854461.SGD","BK4139","LU0266512127.USD","CRC"],"gpt_icon":0},{"id":"2512486933","title":"Nextcure, Inc.盘中异动 早盘股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512486933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512486933?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:50","pubTimestamp":1739976648,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时50分，Nextcure, Inc.股票出现异动，股价急速上涨6.43%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225048a24bfe41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225048a24bfe41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","NXTC","BK4139","CRC","LU0266512127.USD","LU0456854461.SGD"],"gpt_icon":0},{"id":"2511469675","title":"Nextcure, Inc.盘中异动 早盘快速上涨5.84%报0.767美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511469675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511469675?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:46","pubTimestamp":1739544364,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时46分，Nextcure, Inc.股票出现异动，股价大幅拉升5.84%。截至发稿，该股报0.767美元/股，成交量1490股，换手率0.01%，振幅3.51%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224605abcf09d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224605abcf09d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0266512127.USD","NXTC","BK4213","CRC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2511525725","title":"Nextcure, Inc.盘中异动 早盘快速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525725?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457133,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分，Nextcure, Inc.股票出现波动，股价快速下跌5.17%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132232139621bbf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132232139621bbf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","LU0266512127.USD","BK4213","NXTC","CRC","BK4139"],"gpt_icon":0},{"id":"2510805563","title":"Nextcure, Inc.盘中异动 股价大涨8.32%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510805563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510805563?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:35","pubTimestamp":1739284505,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时35分，Nextcure, Inc.股票出现异动，股价大幅上涨8.32%。截至发稿，该股报0.800美元/股，成交量1972股，换手率0.01%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235059881bd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235059881bd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRC","OCEA","NXTC","LU0456854461.SGD","LU0266512127.USD","BK4213"],"gpt_icon":0},{"id":"2510622899","title":"Nextcure, Inc.盘中异动 急速下挫5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510622899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510622899?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:04","pubTimestamp":1739214298,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时04分，Nextcure, Inc.股票出现波动，股价大幅跳水5.25%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211030459961e333f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211030459961e333f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","LU0266512127.USD","LU0456854461.SGD","CRC","NXTC","BK4139"],"gpt_icon":0},{"id":"2509778106","title":"Nextcure, Inc.盘中异动 下午盘大幅跳水6.00%报0.743美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509778106?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:23","pubTimestamp":1738956207,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时23分，Nextcure, Inc.股票出现波动，股价大幅跳水6.00%。截至发稿，该股报0.743美元/股，成交量5.3122万股，换手率0.19%，振幅7.29%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032327961b695a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032327961b695a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4213","LU0456854461.SGD","NXTC","LU0266512127.USD","CRC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nextcure.com","stockEarnings":[{"period":"1week","weight":0.2038},{"period":"1month","weight":-0.2974},{"period":"3month","weight":-0.4972},{"period":"6month","weight":-0.7033},{"period":"1year","weight":-0.7512},{"period":"ytd","weight":-0.4805}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NextCure, Inc.于2015年9月在特拉华州注册成立，总部位于马里兰州贝尔茨维尔。 该公司是一家临床阶段的生物制药公司，致力于发现和开发新型的一流免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。 通过其专有的功能性，集成式，免疫肿瘤学中的NextCure Discovery（“FIND-IO”）平台，公司研究各种免疫细胞，以发现和了解免疫细胞的靶标和结构成分及其功能影响，从而开发免疫组化。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.008161},{"month":2,"riseRate":0.166667,"avgChangeRate":0.025138},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.063149},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.166104},{"month":5,"riseRate":0.4,"avgChangeRate":0.041415},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.033582},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.060834},{"month":8,"riseRate":0.5,"avgChangeRate":0.066323},{"month":9,"riseRate":0,"avgChangeRate":-0.127012},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.032937},{"month":11,"riseRate":0.5,"avgChangeRate":0.052168},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.026607}],"exchange":"NASDAQ","name":"Nextcure Inc.","nameEN":"Nextcure Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nextcure Inc.,NXTC,Nextcure Inc.股票,Nextcure Inc.股票老虎,Nextcure Inc.股票老虎国际,Nextcure Inc.行情,Nextcure Inc.股票行情,Nextcure Inc.股价,Nextcure Inc.股市,Nextcure Inc.股票价格,Nextcure Inc.股票交易,Nextcure Inc.股票购买,Nextcure Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}